Immune Reconstitution in Stem Cell Transplant Recipients



Status:Recruiting
Conditions:Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 75
Updated:1/9/2019
Start Date:August 15, 2012
End Date:December 2021

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Collection of Peripheral Blood Samples From Donors and Recipients of Blood and Marrow Transplants for Laboratory Research in Immune Reconstitution

This specimen collection lab protocol will allow the investigators to prospectively study
immune reconstitution in patients being treated for hematologic disorders and immune factors
affecting graft versus host disease in stem-cell transplant (SCT) patients.


Inclusion Criteria:

Arm A:

- Patients presenting to the clinical services of the Division of Hematology/Oncology,
for treatment of hematologic disorders.

- Age ranging from late adolescence to approximately age 75.

- Including patients with a broad range of hematologic malignancies and bone marrow
failure states.

Arm B:

- Stem Cell Transplant Donor

- Stem Cell Transplant Recipient

- Age range from late adolescence to age 75

Exclusion Criteria:
We found this trial at
1
site
University of Miami
Miami, Florida 33124
(305) 284-2211
Principal Investigator: Krishna Komaduri, MD
Phone: 305-243-6356
University of Miami A private research university with more than 15,000 students from around the...
?
mi
from
Miami, FL
Click here to add this to my saved trials